{"id":"placebo-in-sublingual-applicator","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL5715933","moleculeType":null,"molecularWeight":"612.41"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebos work through multiple psychological and neurobiological pathways including expectation, conditioning, and activation of endogenous pain-relief systems. In a sublingual applicator format, the placebo is designed to be absorbed or dissolved under the tongue, potentially enhancing the ritualistic and sensory components of the placebo response. The therapeutic effect is not due to pharmacological activity of the formulation itself, but rather the patient's belief and the clinical context in which it is administered.","oneSentence":"A placebo in sublingual applicator form produces therapeutic effects through the placebo response mechanism, wherein patient expectation and psychological factors influence symptom perception and outcomes.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:37:00.558Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT05760092","phase":"PHASE2","title":"The Use of Photobiomodulation in the Treatment of Oral Complaints of Long COVID-19.A Randomized Controlled Trial.","status":"COMPLETED","sponsor":"University of Nove de Julho","startDate":"2023-03-01","conditions":"Xerostomia, COVID-19, Long COVID","enrollment":10},{"nctId":"NCT06072573","phase":"PHASE3","title":"Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy","status":"UNKNOWN","sponsor":"Apurano Pharmaceuticals GmbH","startDate":"2023-11-02","conditions":"Pain, Pain Syndrome, Pain, Chronic","enrollment":558},{"nctId":"NCT06071962","phase":"PHASE3","title":"Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain","status":"UNKNOWN","sponsor":"Apurano Pharmaceuticals GmbH","startDate":"2023-11-02","conditions":"Pain, Pain Syndrome, Pain, Chronic","enrollment":558},{"nctId":"NCT06072001","phase":"PHASE3","title":"Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis","status":"UNKNOWN","sponsor":"Apurano Pharmaceuticals GmbH","startDate":"2023-11-02","conditions":"Pain, Pain Syndrome, Pain, Chronic","enrollment":558},{"nctId":"NCT06071949","phase":"PHASE3","title":"Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis","status":"UNKNOWN","sponsor":"Apurano Pharmaceuticals GmbH","startDate":"2023-11-02","conditions":"Pain, Pain Syndrome, Pain, Chronic","enrollment":558},{"nctId":"NCT06071988","phase":"PHASE3","title":"Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy","status":"UNKNOWN","sponsor":"Apurano Pharmaceuticals GmbH","startDate":"2023-11-02","conditions":"Pain, Pain Syndrome, Pain, Chronic","enrollment":558},{"nctId":"NCT06071975","phase":"PHASE3","title":"Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy","status":"UNKNOWN","sponsor":"Apurano Pharmaceuticals GmbH","startDate":"2023-11-02","conditions":"Pain, Pain Syndrome, Pain, Chronic","enrollment":558},{"nctId":"NCT06072560","phase":"PHASE3","title":"Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain","status":"UNKNOWN","sponsor":"Apurano Pharmaceuticals GmbH","startDate":"2023-11-02","conditions":"Pain, Pain Syndrome, Pain, Chronic","enrollment":558},{"nctId":"NCT06071936","phase":"PHASE3","title":"Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy","status":"UNKNOWN","sponsor":"Apurano Pharmaceuticals GmbH","startDate":"2023-11-02","conditions":"Pain, Pain Syndrome, Pain, Chronic","enrollment":558},{"nctId":"NCT05546528","phase":"NA","title":"Photobiomodulation on Major Salivary Glands in Children With Caries Activity","status":"UNKNOWN","sponsor":"University of Nove de Julho","startDate":"2023-01-20","conditions":"Caries,Dental","enrollment":50},{"nctId":"NCT05443022","phase":"PHASE1, PHASE2","title":"Photobiomodulation on the Salivary Glands of Patients With Xerostomia Induced by the Use of Benzodiazepines","status":"UNKNOWN","sponsor":"University of Nove de Julho","startDate":"2022-02-20","conditions":"Xerostomia","enrollment":60},{"nctId":"NCT04028817","phase":"NA","title":"Sublingual Photobiomodulation in Parkinson's Disease","status":"UNKNOWN","sponsor":"University of Nove de Julho","startDate":"2020-09-10","conditions":"Parkinson Disease","enrollment":40},{"nctId":"NCT04034849","phase":"NA","title":"Effects of Photobiomodulation in Burning Mouth Syndrome","status":"COMPLETED","sponsor":"Rosa María López-Pintor Muñoz","startDate":"2018-04-01","conditions":"Burning Mouth Syndrome","enrollment":20},{"nctId":"NCT04010084","phase":"NA","title":"Photobiomodulation in Individuals With Chronic Obstructive Pulmonary Disease","status":"UNKNOWN","sponsor":"University of Nove de Julho","startDate":"2019-08-01","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":30},{"nctId":"NCT03632096","phase":"PHASE2","title":"Photobiomodulation in Salivary Production of Patients With Xerostomy","status":"UNKNOWN","sponsor":"University of Nove de Julho","startDate":"2018-09-10","conditions":"Xerostomia","enrollment":60},{"nctId":"NCT01012882","phase":"PHASE3","title":"Efficacy and Safety of Sublingual Immunotherapy (SLIT)","status":"UNKNOWN","sponsor":"Roxall Medizin","startDate":"2016-11","conditions":"Allergic Rhinitis","enrollment":120},{"nctId":"NCT00264459","phase":"PHASE3","title":"Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen Mixture","status":"COMPLETED","sponsor":"Allergopharma GmbH & Co. KG","startDate":"2003-02","conditions":"Grass Pollen Allergy","enrollment":160},{"nctId":"NCT01052610","phase":"PHASE4","title":"Assessment of Sublingual Immunotherapy in Children Allergic to House Dust Mites","status":"UNKNOWN","sponsor":"Medical University of Lodz","startDate":"2010-06","conditions":"Bronchial Asthma, Allergic Rhinitis","enrollment":100},{"nctId":"NCT00698594","phase":"PHASE4","title":"Comparison of Effectiveness and Safety of Sublingual Immunotherapy in Children With Allergic Rhinitis","status":"COMPLETED","sponsor":"Medical University of Lodz","startDate":"2008-09","conditions":"Allergic Rhinitis","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"placebo in sublingual applicator","genericName":"placebo in sublingual applicator","companyName":"Medical University of Lodz","companyId":"medical-university-of-lodz","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}